Overview

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the drug Leukine (GM-CFS) is safe and tolerated by patients with autoimmune myasthenia gravis (MG).
Phase:
Early Phase 1
Details
Lead Sponsor:
Muscular Dystrophy Association
Treatments:
Molgramostim
Sargramostim